GlassScriptPhysician profile
William M Dutch
NPI 1689666331
$4,796.05
in general payments reported to CMS, 2019-2025
25 companies · $1,330 in 2025
The $1,330 reported for 2025 was more than what 89% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $928 · 2020: $256 · 2021: $112 · 2022: $643 · 2023: $704 · 2024: $823 · 2025: $1,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,856.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,170.77 | 2023-2025 | |
| Organogenesis INC. | $623.33 | 2022-2025 | Puraply Wound Matrix, Puraply Am, Puraply |
| Aroa Biosurgery Incorporated | $504.62 | 2019-2022 | |
| Abbvie INC. | $492.03 | 2022-2024 | Dalvance |
| Paratek Pharmaceuticals, INC. | $310.08 | 2022-2025 | Nuzyra |
| Stryker Corporation | $240.78 | 2019-2020 | |
| Kerecis Limited | $224.61 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Linvatec Corporation | $162.50 | 2023 | Biobrace 23mm |
| Advanced Oxygen Therapy INC. | $128.87 | 2019-2020 | |
| Integra Lifesciences Corporation | $128.05 | 2019 | |
| Depuy Synthes Sales INC. | $112.45 | 2022 | |
| Hydrofera LLC | $111.03 | 2021-2023 | Hydrofera Blue |
| Kci USA, INC. | $106.13 | 2019 | |
| Mimedx Group, INC. | $90.60 | 2025 | |
| Acell, INC. | $89.76 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $50.74 | 2019-2023 | Collagenase Santyl |
| Fidia Pharma USA INC. | $48.01 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $45.71 | 2023-2024 | Exparel |
| Avanos Medical | $28.00 | 2022 | |
| Bioventus LLC | $25.92 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $25.30 | 2025 | |
| Heron Therapeutics, INC. | $22.93 | 2021 | |
| Stimwave Technologies Incorporated | $21.60 | 2022 | |
| Nabriva Therapeutics, Plc | $21.07 | 2022 | |
| Merck Sharp & Dohme LLC | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dutch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.